Orthofix Medical Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Orthofix Medical Inc. (OFIX) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $7.74 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-05
- Orthofix Medical Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $7.74M, a 1.14% decline year-over-year.
- Orthofix Medical Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $6.53M, a 0.99% increase year-over-year.
- Orthofix Medical Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $7.18M, a 9.95% increase year-over-year.
- Orthofix Medical Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $7.82M, a 21.44% decline year-over-year.
- Orthofix Medical Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $28.69M, a 11.61% decline from fiscal 2024.
- Orthofix Medical Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $32.45M, a 9.11% decline from fiscal 2023.
- Orthofix Medical Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $35.71M, a 93.61% increase from fiscal 2022.
- Orthofix Medical Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $18.44M, a 19.51% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.74M 10-Q · filed 2026-08-05 | $14.27M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $6.53M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $28.69M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $7.18M 10-Q · filed 2025-11-04 | $15.01M derived: sum of 2 quarters · filed 2026-08-05 | $21.47M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-06-30 | $7.82M 10-Q · filed 2026-08-05 | $14.29M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $6.47M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $32.45M 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $6.53M 10-Q · filed 2025-11-04 | $16.49M derived: sum of 2 quarters · filed 2025-11-04 | $25.29M derived: sum of 3 quarters · filed 2025-11-04 | |
| 2024-06-30 | $9.96M 10-Q · filed 2025-11-04 | $18.76M derived: sum of 2 quarters · filed 2025-11-04 | ||
| 2024-03-31 | $8.80M 10-Q · filed 2025-11-04 | |||
| 2023-12-31 | $35.71M 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $6.27M 10-Q · filed 2024-11-07 | $19.52M derived: sum of 2 quarters · filed 2024-11-07 | $32.54M derived: sum of 3 quarters · filed 2024-11-07 | |
| 2023-06-30 | $13.25M 10-Q · filed 2024-11-07 | $26.27M derived: sum of 2 quarters · filed 2024-11-07 | ||
| 2023-03-31 | $13.02M 10-Q · filed 2024-11-07 | |||
| 2022-12-31 | $18.44M 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $4.73M 10-Q · filed 2023-11-08 | $9.19M derived: sum of 2 quarters · filed 2023-11-08 | $13.52M derived: sum of 3 quarters · filed 2023-11-08 | |
| 2022-06-30 | $4.46M 10-Q · filed 2023-11-08 | $8.79M derived: sum of 2 quarters · filed 2023-11-08 | ||
| 2022-03-31 | $4.33M 10-Q · filed 2023-11-08 | |||
| 2021-12-31 | $15.43M 10-K · filed 2024-03-05 | |||
| 2021-09-30 | $3.84M 10-Q · filed 2022-11-03 | $7.75M derived: sum of 2 quarters · filed 2022-11-03 | $11.47M derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | $3.91M 10-Q · filed 2022-11-03 | $7.63M derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2021-03-31 | $3.72M 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $16.21M 10-K · filed 2023-03-06 | |||
| 2020-09-30 | $3.84M 10-Q · filed 2021-11-05 | $8.54M derived: sum of 2 quarters · filed 2021-11-05 | $12.40M derived: sum of 3 quarters · filed 2021-11-05 | |
| 2020-06-30 | $4.70M 10-Q · filed 2021-11-05 | $8.56M derived: sum of 2 quarters · filed 2021-11-05 | ||
| 2020-03-31 | $3.86M 10-Q · filed 2021-11-05 | |||
| 2019-12-31 | $21.54M 10-K · filed 2022-02-25 | |||
| 2019-09-30 | $5.84M 10-Q · filed 2020-11-05 | $11.69M derived: sum of 2 quarters · filed 2020-11-05 | $17.38M derived: sum of 3 quarters · filed 2020-11-05 | |
| 2019-06-30 | $5.85M 10-Q · filed 2020-11-05 | $11.53M derived: sum of 2 quarters · filed 2020-11-05 | ||
| 2019-03-31 | $5.68M 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $18.93M 10-K · filed 2021-02-26 | |||
| 2018-09-30 | $5.26M 10-Q · filed 2019-10-28 | $10.48M derived: sum of 2 quarters · filed 2019-10-28 | $14.39M derived: sum of 3 quarters · filed 2019-10-28 | |
| 2018-06-30 | $5.21M 10-Q · filed 2019-10-28 | $9.13M derived: sum of 2 quarters · filed 2019-10-28 | ||
| 2018-03-31 | $3.92M 10-Q · filed 2019-10-28 | |||
| 2017-12-31 | $12.56M 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $15.97M 10-K · filed 2019-02-25 | |||
| 2015-12-31 | $7.21M 10-K · filed 2018-02-26 | |||
| 2014-12-31 | $5.72M 10-K · filed 2017-02-27 | |||
| 2013-12-31 | $6.27M 10-K · filed 2016-02-29 | |||
| 2012-12-31 | $6.30M 10-K · filed 2015-04-29 | |||
| 2011-12-31 | $6.65M 10-K/A · filed 2015-03-31 | |||
| 2010-12-31 | $8.14M 10-K/A · filed 2014-03-24 | |||
| 2009-12-31 | $10.75M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |